
2022 LFB corporate Brochure: discover the Denis Delval edito in video

Discover the new LFB CSR Charter

The new LFB Arras plant in video

LFB and Kedrion sign an industrial cooperation agreement to supply immunoglobulins in France

Interview with Denis Delval

Bruno de Miribel joins LFB

LFB works for « the France of tomorrow » and unveils a new industrial project in Alès

EMA acceptance for filing of the MARKETING AUTHORISATION application FOR EPTACOG BETA, THE LFB RECOMBINANT FACTOR VIIA , AND PUBLICATION OF THE EXPLORATORY IN VITRO STUDY RESULTS on eptacog beta in combination with emicizumab
IN 2021
BIOPRODUCTION SITES in the world
IN THE FIELD OF PLASMA-DERIVED MEDICINAL PRODUCTS
prescribed to
hospital
of LFB’s biomedicinal products are intended for the treatment of patients with rare diseases
- Immunology
- Haemostasis
- Intensive Care

3:24
THE NEW LFB ARRAS PLANT, January 2022
there is 3 months

3:13
Part 3 : LFB's values
there is 12 months

2:38
Part 2 : the new Momentum
there is 12 months

3:32
Part 1: three years of LFB transformation
there is 1 year